211078 (NASDAQ:ACCL)
Industry: Technology

Accelrys, Inc. develops and commercializes scientific business intelligence software and solutions in the United States, Europe, and the Asia Pacific. The company offers Accelrys Enterprise Platform and Pipeline Pilot, which allows users to aggregate, mine, manage, analyze, and report on the structured and unstructured scientific data; and filters, normalizes, and performs statistical analysis on the scientific data and provides interactive visual reports to scientists and scientific managers. It also provides modeling and simulation software that allows scientists to perform computations of chemical, biological, and materials properties to simulate, visualize, and analyze chemical and biological systems, as well as communicate the results to other scientists; and data management and informatics software to search, retrieve, and use chemical structures, biological and chemical data, experimental data, and registration information. In addition, the company offers Enterprise Lab Notebook, which provides a digital environment to plan, execute, record, store, back-up, and share daily research activities; lab execution systems; and content databases covering bioactivity, chemical sourcing, molecular properties, synthetic methodology, metabolism, and toxicology information. Further, it provides software wrappers that allow customers to run their own algorithms on the company s R&D platform; enterprise-wide informatics systems, which integrate customers internal systems with software from various vendors; contract research services; onsite training and implementation, Web-based training, and data migration services; and support services. The company serves pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods, life science, and industrial products industries, as well as government and academic entities through direct sales force, telesales, and distributors. Accelrys, Inc. was founded in 1993 and is headquartered in San Diego, California.

Current Quote*
Last: $12.510
Change: 0.000
Book: $2.800
Volume: 28,723

As Of: 01/02 15:59 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol ACCL

  • No BuyIns.Net Alerts Available for ACCL

Graphs for ACCL


3 Month Graph


6 Month Graph


1 Year Graph